PDCD1 and neoplasm: In order to understand whether circulating cell-specific extracellular vesicles may serve as monitoring biomarkers of response to anti-PD1, we performed the quantification of PD1+EVs, PD-L1+EVs and uPAR+EV sub-populations released from tumor cells and immune cells at different time of disease re-evaluation.